SCHEMBL20118741

SCHEMBL20118741

CCCCN(CCC)CCNC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.44
PRMT3 O60678 1/20 0.40
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
PRMT1 Q99873 1/20 0.40
PRMT8 Q9NR22 1/20 0.40
KDM5A P29375 3/20 0.35
PHF8 Q9UPP1 2/20 0.33
KDM4C Q9H3R0 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA9 Q16790 2/20 0.32
KMT2A Q03164 2/20 0.32
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
MAPT P10636 1/20 0.31
ALDH1A1 P00352 2/20 0.31
TSHR P16473 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065809 0.95 EPHX1 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL681618 0.95 EPHX1 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL18732127 0.93 EPHX1 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL9947081 0.90 PRMT3 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL8851267 0.90 PRMT3 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL12478475 0.86 EPHX1 (0.44) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL19575770 0.86 EPHX1 (0.44) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL21501557 0.85 EPHX1 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL681370 0.85 EPHX1 (0.55) EPHX1PRMT3CARM1PRMT6PRMT1
SCHEMBL10811942 0.85 EPHX1 (0.48) EPHX1PRMT3CARM1PRMT6PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269417-A1 POLYSUBSTITUTED IMIDAZOLE[4,5-C][1,2]THIAZINE DERIVATIVE AND USE THEREOF Kyungpook National University Industry-Academic Cooperation Foundation (KR) 2023-11-01 EP disclosed
US-10723837-B2 Method of preparing poly(alkylene carbonate) via copolymerization of carbon dioxide/epoxide in the presence of novel complex SK INNOVATION CO., LTD. (KR) 2020-07-28 US disclosed
US-20180223042-A1 Method of Preparing Poly(Alkylene Carbonate) via Copolymerization of Carbon Dioxide/Epoxide in the Presence of Novel Complex SK INNOVATION CO., LTD. (KR) 2018-08-09 US disclosed
US-9969842-B2 Method of preparing poly(alkylene carbonate) via copolymerization of carbon dioxide/epoxide in the presence of novel complex SK INNOVATION CO., LTD. (KR) 2018-05-15 US disclosed
EP-3315531-A1 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY Xiamen Sinopeg Biotech Co., Ltd. (CN) 2018-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10723837-B2 Method of preparing poly(alkylene carbonate) via copolymerization of carbon dioxide/epoxide in the presence of novel complex SMARCC2, SMARCC1, CLNS1A EPHX1 1159/4885PRMT3 4222/4885CARM1 1779/4885
US-20180223042-A1 Method of Preparing Poly(Alkylene Carbonate) via Copolymerization of Carbon Dioxide/Epoxide in the Presence of Novel Complex SMARCC2, SMARCC1, CLNS1A EPHX1 1159/4885PRMT3 4222/4885CARM1 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.